Yoshiyasu Iida

2.6k total citations · 1 hit paper
14 papers, 2.0k citations indexed

About

Yoshiyasu Iida is a scholar working on Nephrology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Yoshiyasu Iida has authored 14 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 4 papers in Clinical Biochemistry and 3 papers in Molecular Biology. Recurrent topics in Yoshiyasu Iida's work include Advanced Glycation End Products research (4 papers), Chronic Kidney Disease and Diabetes (4 papers) and Dialysis and Renal Disease Management (4 papers). Yoshiyasu Iida is often cited by papers focused on Advanced Glycation End Products research (4 papers), Chronic Kidney Disease and Diabetes (4 papers) and Dialysis and Renal Disease Management (4 papers). Yoshiyasu Iida collaborates with scholars based in Japan, India and Belgium. Yoshiyasu Iida's co-authors include Toshio Miyata, Taroh Kinoshita, Teruo Kitani, Minoru Takahashi, Junji Takeda, Kenji Maeda, Yuichi Endo, Teizo Fujita, Norio Yamada and Yoshinao Wada and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Yoshiyasu Iida

13 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria

1993 782 citations Junji Takeda, Toshio Miyata et al. Cell profile →

Peers

Countries citing papers authored by Yoshiyasu Iida

Since Specialization

Citations

This map shows the geographic impact of Yoshiyasu Iida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyasu Iida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyasu Iida more than expected).

Fields of papers citing papers by Yoshiyasu Iida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiyasu Iida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyasu Iida. The network helps show where Yoshiyasu Iida may publish in the future.

Co-authorship network of co-authors of Yoshiyasu Iida

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiyasu Iida. A scholar is included among the top collaborators of Yoshiyasu Iida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiyasu Iida. Yoshiyasu Iida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Prevalence, Determinants, and Reasons for the Non-Reporting of Adverse Drug Reactions by Pharmacists in the Miyagi and Hokkaido Regions of Japan 2015 ·Taku Obara, Hiroaki Yamaguchi, Michihiro Satoh, Yoshiyasu Iida	7
2	Efficacy and safety of fluoroscopic manipulation using the alpha-replacer for peritoneal catheter malposition 2014 ·Clinical and Experimental Nephrology ·Yosuke Saka, Yasuhiko Ito, Yoshiyasu Iida, Shoichi Maruyama, Seiichi Matsuo	4
3	Icodextrin eliminates phosphate and ameliorates cardiac hypertrophy and valvular calcification in patients with end-stage renal disease and diabetes mellitus undergoing peritoneal dialysis. 2013 ·PubMed ·Takeyuki Hiramatsu, (unknown), (unknown), (unknown), Koki Kabu, (unknown), Yoshiyasu Iida	5
4	When should icodextrin be started to improve atherosclerosis in peritoneal dialysis patients? 2013 ·PubMed ·Takeyuki Hiramatsu, (unknown), (unknown), (unknown), Koki Kabu, (unknown), Yoshiyasu Iida	1
5	A case of Wernicke's encephalopathy associated with the introduction of hemodialysis 2009 ·Nihon Toseki Igakkai Zasshi ·(unknown), (unknown), (unknown), Yoshiyasu Iida, (unknown), (unknown), (unknown)	0
6	Functional quantitative analysis of the genome in cultured human mesangial cells: Technical Note 1998 ·Kidney International ·Yoshinari Yasuda, Toshio Miyata, Masaomi Nangaku, Yoshiyasu Iida, Kenji Maeda, Kiyoshi Kurokawa, Kousaku Okubo	21
7	Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy 1997 ·Kidney International ·Toshio Miyata, (unknown), Atsuhiro Yoshida, (unknown), Yoshiyasu Iida, Michel Jadoul, Kenji Maeda, Kiyoshi Kurokawa, Charles van Ypersele de Strihou	111
8	Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure 1997 ·Kidney International ·Toshio Miyata, Yoshinao Wada, Zhe Cai, Yoshiyasu Iida, Katsunori Horie, Yoshinari Yasuda, Kenji Maeda, Kiyoshi Kurokawa, Charles van Ypersele de Strihou	313
9	Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products 1996 ·Kidney International ·Toshio Miyata, Yoshiyasu Iida, Yasuhiko Ueda, Toru Shinzato, Hisao Seo, Vincent M. Monnier, Kenji Maeda, Yoshinao Wada	70
10	Abnormalities of PIG-A Transcripts in Granulocytes from Patients with Paroxysmal Nocturnal Hemoglobinuria 1994 ·New England Journal of Medicine ·Toshio Miyata, Norio Yamada, Yoshiyasu Iida, Jun‐ichi Nishimura, (unknown), Teruo Kitani, Taroh Kinoshita	193
11	Glycation of Human .beta.2-Microglobulin in Patients with Hemodialysis-Associated Amyloidosis: Identification of the Glycated Sites 1994 ·Biochemistry ·Toshio Miyata, Reiko Inagi, Yoshinao Wada, Yasuhiko Ueda, Yoshiyasu Iida, Motoko Takahashi, Naoyuki Taniguchi, Kenji Maeda	46
12	Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria breakdown → 1993 ·Cell ·Junji Takeda, Toshio Miyata, (unknown), Yoshiyasu Iida, Yuichi Endo, Teizo Fujita, Minoru Takahashi, Teruo Kitani, Taroh Kinoshita	782
13	The Cloning of PIG-A, a Component in the Early Step of GPI-Anchor Biosynthesis 1993 ·Science ·Toshio Miyata, Junji Takeda, Yoshiyasu Iida, Norio Yamada, Norimitsu Inoue, Minoru Takahashi, Kenji Maeda, Teruo Kitani, Taroh Kinoshita	420
14	Fluid-Phase Activation of the Alternative Pathway of Complement by Excess Factor D in Regularly Dialyzed Patients 1992 ·The Nephron journals/Nephron journals ·Toshio Miyata, Reiko Inagi, (unknown), Yoshiyasu Iida, Osamu Oda, Taroh Kinoshita, Kozo Inoue, Akio Miyama, Kenji Maeda	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact